You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

795 Results
Document
Dec 1969
Document
Dec 1969
Guidelines and Advice
Status: Current
ID: GL 8-10
Version: N/A
Dec 1969
Document
Dec 1969
Document
Dec 1969
Document
Mar 2020
Document
Mar 2020
Document
Mar 2020
Document
Mar 2020
Document
Mar 2020
Document
Mar 2020
Regimen
Cancer Type:
Central Nervous System
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    lomustine
New Drug Funding Program
    Bevacizumab (Biosimilar) - In Combination with Lomustine for Recurrent Glioblastoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
lomustine,
bevacizumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph

Pages